SAS-B approvals exceed 20,000 for third successive month by Steve Jones August 6, 2026August 6, 2026 Prescriptions through the Special Access Scheme hit the second highest of the year in July with […]
Emyria losses deepen as drug development takes centre stage by Steve Jones March 1, 2022April 29, 2024
UNSW and e3D Pharma join forces to test treatment potential of cannabinoids for PTSD and anxiety by Martin Lane June 28, 2021April 26, 2024
Campaigners for military veterans dumbfounded after Cannabiz discovers DVA has funded cannabis for PTSD – and even psoriasis by Rhys Cohen June 17, 2021April 26, 2024
Hope for cannabis campaigners as royal commission is launched into veteran suicides by Steve Jones April 20, 2021April 26, 2024
Plight of PTSD victim stirs support as momentum builds to help stricken military veterans by Steve Jones April 8, 2021April 26, 2024
